BioCardia, Inc.
Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 21 Aug 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 12 Jun 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 15 Apr 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →BioCardia, Inc. — Overview & Financial Snapshot
BioCardia, Inc. (NasdaqCM: BCDA) is a Healthcare company, ranked #6,577 of 6,774 companies globally and #3,821 of 4,000 in United States on PositoAI, with a Positivity Score of -26,367. Its market capitalisation is ₹132.71 Cr ($14.06M), P/E ratio is -1.5 and P/B ratio is -13.19. It currently has 3 active red flags (PosiRed) and no yellow flags (PosiYellow) on record.
For financial statements, ratio trends and score history, Go Deep →